Allogeneic Neonatal mesenchymal stromal cells therapy(Emory University)

N/A

Report date: 2024/06/19 20:00:11

Base Information

Drug NameAllogeneic Neonatal mesenchymal stromal cells therapy(Emory University)
Drug Alias NameAllogeneic Neonatal Mesenchymal Cells (nMSCs)therapy(Emory University)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsCardiomyopathy, Dilated
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEmory UniversityThe Marcus Foundation
China Registration ClassN/A

Develop Information

Active CompaniesThe Marcus FoundationEmory University
Inactive CompaniesN/A
Active IndicationsCardiomyopathy, Dilated
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A